Auckland, New Zealand

Ralph James Stevenson


Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ralph James Stevenson: Innovator in Cancer Therapy

Introduction

Ralph James Stevenson is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of cancer therapy through his innovative research and patented inventions. With a total of two patents, Stevenson is recognized for his work in developing novel compounds aimed at improving cancer treatment.

Latest Patents

Stevenson's latest patents include "Nitrobenzindoles and their use in cancer therapy." This invention focuses on nitro-1,2-dihydro-3H-benzo[e]indoles and related analogues, detailing their preparation and application as hypoxia-selective drugs and radiosensitizers for cancer therapy. These compounds can be used alone or in combination with radiation and other anticancer drugs. Another significant patent is "Anti-cancer 2,3-dihydro-1H-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium." This invention pertains to a class of heterocycles and their metal complexes, emphasizing their use in preparing prodrugs that can be activated under hypoxic conditions for cancer treatment.

Career Highlights

Ralph James Stevenson is associated with Auckland Uniservices Limited, where he continues to advance his research in cancer therapy. His work has garnered attention for its potential to enhance the effectiveness of cancer treatments through innovative drug design.

Collaborations

Stevenson has collaborated with notable colleagues, including William Alexander Denny and William Robert Wilson. These partnerships have contributed to the development of his groundbreaking inventions.

Conclusion

Ralph James Stevenson is a prominent figure in the field of cancer therapy, with innovative patents that hold promise for improving treatment outcomes. His contributions reflect a commitment to advancing medical science and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…